|
Model without IMF as covariate
|
Model with IMF as covariate
|
---|
Trait*
|
LRT
|
p-value
|
Effect allele A
|
SE
|
Effect allele G
|
SE
|
Var [%]**
|
LRT
|
p-value
|
Effect allele A
|
SE
|
Effect allele G
|
SE
|
---|
Total FA [mg]*&
|
6.2
|
0.0130
|
3.70
|
0.07
|
3.88
|
0.07
| |
3.8
|
0.0507
| | | | |
MUFA [mg]*&
|
5.9
|
0.0154
|
3.29
|
0.08
|
3.48
|
0.09
| |
2.9
|
0.0874
| | | | |
n-3 FA [%]*#
|
9.7
|
0.0018a
|
0.16
|
0.05
|
0.01
|
0.06
|
11.4
|
5.8
|
0.0159
|
0.42
|
0.04
|
0.36
|
0.04
|
PUFA [%]*#
|
7.1
|
0.0079b
|
1.12
|
0.05
|
0.98
|
0.06
|
3.5
|
3.9
|
0.0477
| | | | |
n-3 LC PUFA [%]#
|
6.7
|
0.0099b
|
0.24
|
0.03
|
0.16
|
0.04
|
3.4
|
3.5
|
0.0628
| | | | |
C18:1trans-11 [mg]*&
|
10.5
|
0.0012a
|
1.31
|
0.10
|
1.63
|
0.12
|
6.5
|
8.1
|
0.0045a
|
0.86
|
0.09
|
1.07
|
0.10
|
C22:5n-3 [%]#
|
7.2
|
0.0071 b
|
0.16
|
0.02
|
0.11
|
0.03
|
3.6
|
5.9
|
0.0150
|
0.27
|
0.02
|
0.23
|
0.02
|
PUFA/SFA*
|
7.3
|
0.0069b
|
-0.79
|
0.06
|
-0.94
|
0.07
|
3.6
|
4.2
|
0.0407
| | | | |
P/S*
|
6.7
|
0.0099b
|
-1.02
|
0.05
|
-1.15
|
0.06
|
3.2
|
3.2
|
0.0758
| | | | |
LA/ALA*
|
4.9
|
0.0265
|
1.03
|
0.03
|
0.97
|
0.03
| |
1.9
|
0.1720
| | | | |
IMF [%]
|
3.1
|
0.0776
|
1.11
|
0.18
|
1.42
|
0.21
|
1.7
| | | | | | |
- *Trait data log-transformed, &absolute content of fatty acids (mg/100 g of skeletal muscle), #relative content of fatty acids (percentage of the respective fatty acid fraction relative to total fatty acid amount)
- LTR: likelihood ratio test, p: significancy of allelic effects, Var: variance explained, SE: standard error, aq-value <0.05, bq-value <0.1, **% variance in the model calculated as the relative reduction of the residual variance due to including the SNP in the model [47].
- Allelic effects of the ACSL1 SNP (c.481-233A>G) on different FA fractions: n-3 fatty acids (n-3 FA = C18:3n-3 + C18:4n-3 + C20:5n-3 + C22:5n-3 + C22:6n-3), poly-unsaturated fatty acids (PUFA = n-3 FA + n-6 FA [C18:2n-6 + C18:3n-6 + C20:2n-6 + C20:3n-6 + C20:4n-6 + C22:2n-6 + C22:4n-6]), n-3 long-chain PUFA (n-3 LC-PUFA = C20:3n-3 + C22:6n-3 + C22:5n-3 + C20:5n-3), total FA, mono-unsaturated fatty acids (MUFA), docosapentaenoic fatty acid (DPA, C22:5n-3), trans vaccenic acid (TVA, C18:1trans-11) and the ratios: PUFA/SFA (saturated fatty acids = C12:0 + C14:0 + C16:0 + C17:0 + C18:0 + C20:0 + C24:0), P/S (C18:2 n-6 + C18:3 n-3/C14:0 + C16:0 + C18:0), LA/ALA (C18:2 n-6/C18:3 n-3), and the intramuscular fat content (IMF).